Home/Smart Money/Elmind Capital, LP
§ 13F · FUND PROFILE

Elmind Capital, LP.

AUM · $398M (13F)Positions · 35Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
No new positions
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS

The book · Q2 2026

FILED AUG 14, 2026
#TickerNameShares$ value% portΔ Q2
1COGTCOGENT BIOSCIENCES INC1.17M$45M
2SNDXSYNDAX PHARMACEUTICALS INC1.85M$41M
3CLDXCELLDEX THERAPEUTICS INC NEW990K$37M
4RLAYRELAY THERAPEUTICS INC1.47M$27M
5PCVXVAXCYTE INC452K$26M
6VERAVERA THERAPEUTICS INC437K$19M
7PHVSPHARVARIS N V526K$18M
8VRDNVIRIDIAN THERAPEUTICS INC985K$18M
9CTMXCYTOMX THERAPEUTICS INC.4.55M$17M
10TVTXTRAVERE THERAPEUTICS INC293K$17M
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE ELMIND SIGNAL

AC read

Elmind Capital, LP is a Other fund managing $398 million in assets. The fund runs a portfolio of 35 positions.

Read the full dossier →